sitagliptin tiefenbacher 25 mg filmom obalené tablety
alfred e. tiefenbacher (gmbh & co. kg), nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
ansifora 50 mg filmom obalené tablety
vipharm s.a., poľsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin hcs 100 mg filmom obalené tablety
hcs bvba, belgicko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin hcs 50 mg filmom obalené tablety
hcs bvba, belgicko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin hcs 25 mg filmom obalené tablety
hcs bvba, belgicko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
onglyza
astrazeneca ab - saxagliptin - diabetes mellitus, typ 2 - lieky používané pri cukrovke - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
starlix
novartis europharm limited - nateglinid - diabetes mellitus, typ 2 - lieky používané pri cukrovke - nateglinid je indikovaný pre kombinovanú liečbu s metformínom u pacientov s diabetom 2. typu, ktoré sú nedostatočne kontrolované napriek maximálnej tolerovanej dávke samotného metformínu.
amaryl 2 mg
sanofi winthrop industrie, francúzsko - glimepirid - 18 - antidiabetica (vrÁtane inzulÍnu)
amaryl 3 mg
sanofi winthrop industrie, francúzsko - glimepirid - 18 - antidiabetica (vrÁtane inzulÍnu)
amaryl 4 mg
sanofi winthrop industrie, francúzsko - glimepirid - 18 - antidiabetica (vrÁtane inzulÍnu)